期刊文献+

HPLC法测定己烯雌酚软膏中己烯雌酚的含量 被引量:2

Determination of Diethylstilbestrol in Compound Diethylstilbestrol Ointment by HPLC
下载PDF
导出
摘要 目的:建立测定己烯雌酚软膏中己烯雌酚(DES)含量的高效液相色谱(HPLC)检验方法.方法:采用Nova-PaKC18色谱柱(150mm×4.6mm,5μm),流动相为甲醇-水(75:25),流速为1.0mL/min,检测波长为254nm.结果:己烯雌酚在10.08~80.64pg/ml范围内含量与峰面积比呈现良好的线性关系y=2×106×-5433.4(r=0.9999),平均回收率为98.67%,RSD为0.3%.结论:本法能准确检测已烯雌酚软膏中的己烯雌酚含量,因此可作为已烯雌酚质量控制的有效测量方法. Objective:A HPLC method was established for the determination of diethylstilbestrol in compound diethylstilbestrol ointment. Methods:A Nova-PaKC 18(150mm×4.6mm,5μm) column was used with the mobile phase of methanol-water(75:25)at the detection wavelength of 254nm.The flow rate was 1.0ml/min.Results:The linear range was(10.08±80.64)μg/ml (r=0.9999).The average recovery and RSD were 98.67% and 0.3% respectively. Conlusion:The method could be used for the determination of diethylstilbestrol in compound diethylstilbestrol ointment. Therefore it could be used as a effective quality control method for diethylsfilbestrol ointment.
出处 《中国医药导刊》 2010年第6期1093-1094,共2页 Chinese Journal of Medicinal Guide
关键词 已烯雌酚软膏 高效液棚色谱法 已烯雌酚 Diethylstilbestrol ointment Diethylstilbestrol HPLC
  • 相关文献

参考文献3

二级参考文献18

  • 1Kishi R,Sata F,Saijo Y,et al.Exposure to endocrine disrupting chemicals and children's health:problems in epidemiological studies[J].Nippon Eiseigaku Zasshi,2006,61(1):19~31.
  • 2Korshin G V,Kim J,Gan L.Comparative study of reactions of endocrine disruptors bisphenol A and diethylstilbestrol in electrochemical treatment and chlorination[J].Water Res,2006,11:1070~1078.
  • 3Li S,Hursting S D,Davis B J,et al.Environmental exposure,DNA methylation,and gene regulation:lessons from diethylstilbestrol-induced cancers[J].Ann N Y Acad Sci,2003,983:161~169.
  • 4Newbold R R,Hanson R B,Jefferson W N,et al.Proliferative lesions and reproductive tract tumours in male descendants of mice exposed developmentally to diethylstilbestrol.Carciinogenesis,2000,21(7):1355~1363.
  • 5Papiernik E,Pons J C,Hessabi M.Obstetrical outcome in 454 woman exposed to diethylstilbestrol during their fetal life:a case-control analysis[J].J Gynecol Obstet Biol Reprod(Paris),2005,34(1):33~40.
  • 6Scherr D,Pitts E R J,Vaughn E D J.Diethylstilbestrol revisited:androgen deprivation,osteoporosis and prostate cancer[J].Urol,2002,167(2):535~538.
  • 7Schneider H P G,A O Mueck,H Kuhl.IARC Monographs Program on Carcinogenicity of Combined Hormonal Contraceptives and Menopausal Therapy[J].Presidential Comment,2005.
  • 8Stefanick M L.Estrogens and progestins:background and history,trend in use,and guidelines and regimens approved by the US Food and Drug Administration[J].Am Med,2005,19(118):64~73.
  • 9Shukuwa K,Izumi S I,Hishikawa Y,et al.Diethylstilbestrol increase the density of prolactin cells in male mouse pituitary by inducing proliferation of prolactin cells and transdifferentiation of gonadotropic cells[J].Histochem Cell Biol,2006,9:1~13.
  • 10Waalkes M P,Liu J,Ward J M,et al.Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment[J].Cancer Res,2006,66(3):1337~1345.

共引文献21

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部